Overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: a scoping review using a systematic approach
Objectives The use of cannabis-based medicine (CBM) as a therapeutic has surged in Australia over the past 5 years. Historically, the United Nations Single Convention on Narcotic Drugs (1961) prohibited cannabis use in Europe, the USA, the UK and Australia, l…
Introduction
The emergence of Cannabis sativa as a therapeutic can be dated back to 2700 BC, with use becoming widely adopted in the USA by the 19th century.1 2 Since then, both recreational and med…